Markus Eckstein

Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer

Sebastian Foersch, Christina Glasner, Ann-Christin Woerl et al. · Nature Medicine · 2023 · 237 citations

Medicine, Therapy Response, Prognosis +10

The Tumor Immune Microenvironment Drives a Prognostic Relevance That Correlates with Bladder Cancer Subtypes

Carolin Pfannstiel, Pamela L. Strissel, Katherine B. Chiappinelli et al. · Cancer Immunology Research · 2019 · 224 citations

Immunology, Biological Microenvironments, Pathology +20

Deep Learning Predicts Molecular Subtype of Muscle-invasive Bladder Cancer from Conventional Histopathological Slides

Ann-Christin Woerl, Markus Eckstein, Josephine Geiger et al. · European Urology · 2020 · 174 citations

Urology, Genitourinary Cancer, Tumor Heterogeneity +9

Results from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in muscle invasive bladder cancer (MIBC) undergoing cystectomy.

Shilpa Gupta, Guru Sonpavde, Christopher Weight et al. · Journal of Clinical Oncology · 2020 · 134 citations

Radical Cystectomy, Surgical Oncology, Urology +12

Bispecific T cell engager therapy for refractory rheumatoid arthritis

Laura Bucci, Melanie Hagen, Tobias Rothe et al. · Nature Medicine · 2024 · 121 citations

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +8